KU 204 (Montelukast sodium (chewable) 4 mg (base))
Pill imprint KU 204 has been identified as Montelukast sodium (chewable) 4 mg (base).
Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; copd; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 4 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).
- KU 204
- 4 mg (base)
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Kremers Urban Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- butylated hydroxyanisole
hydroxypropyl cellulose (type h)
ferric oxide red
sodium stearyl fumarate
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
More about montelukast
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 226 Reviews – Add your own review/rating
- Drug class: leukotriene modifiers
Other brands: Singulair
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.